Corporate Governance

As an AIM quoted company, we recognise and prioritise the importance of sound corporate governance principles in supporting and delivering the strategy of the Company and its subsidiaries (the “Group”) and embedding these within, and as an integral part of, the operations of the Group. The Board of Directors (the “Board”) adopted the Quoted Companies Alliance Corporate Governance Code (the “QCA Code”) on the Company’s initial public offering to the market in March 2019. Further information about our approach to governance, the operation of the Board and its committees and how the Group seeks to comply with the ten principles of the QCA Code is available to view on Page 54 of our Annual Report.

The Board has overall responsibility for ensuring that appropriate corporate governance principles are in place and that these requirements are followed and applied across the Group. The corporate governance arrangements are designed, inter-alia, to protect and respect the interests of all stakeholders, to ensure that the Company is managed for the long-term benefit of the Group’s shareholders and other stakeholders, and to provide shareholders and other stakeholders the opportunity to express their views and expectations for the Group in a manner that encourages open and ongoing dialogue with the Board.

Information Update
This information was last updated on: Oct 2026

Aim Rule 26
Access the information required under AIM Rule 26, including company details, constitutional documents, shareholder information, regulatory announcements and key investor disclosures.
View
Board of directors
Meet the Diaceutics Board of Directors and learn more about the experience, oversight and governance responsibilities that support the company’s long-term strategy.
View
Social Responsibility
Explore how Diaceutics approaches environmental, social and governance responsibilities as part of building a sustainable, responsible and trusted business.
View

INVESTOR ALERTS

Sign up to receive the latest Diaceutics investor news, reports and regulatory announcements.